{
  "docId": "019de072-7463-7169-8f31-7c4d89e9eac4",
  "docSlug": "d88eea3c6872c4e67cae911eb0680043",
  "documentTitle": "argenx SE | Results Presentation Deck | 10 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 10,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "appendix_disclosure",
  "function": "preempt_rebuttal",
  "density": "balanced",
  "nDataPoints": 20,
  "notes": "The slide serves as a safety disclosure to preempt concerns regarding mortality in the clinical trial.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-7463-7169-8f31-7c4d89e9eac4/8",
  "deckHref": "/decks/019de072-7463-7169-8f31-7c4d89e9eac4",
  "deckJsonHref": "/decks/019de072-7463-7169-8f31-7c4d89e9eac4.json",
  "deckAnchorHref": "/decks/019de072-7463-7169-8f31-7c4d89e9eac4#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.78,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "CTO PTI, chronic total occlusion percutaneous coronary intervention; CV, cardiovascular; MI, myocardial infarction; MG, myasthenia gravis; PBO, placebo; PI, principal investigator.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "73feda65-5877-49a7-adfa-287fe3b29a85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.68,
        "w": 0.94,
        "x": 0.03,
        "y": 0.192
      },
      "kind": "table",
      "text": "Table showing Age/Sex, Cause of Death, Days from last dose, and Comorbidities for 5 patients.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e63cb1d4-1628-4d57-befa-2b7739dee515",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Deaths in ADAPT+: None Related to Efgartigimod per Investigator",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e67a4ec9-5ea4-4165-ad6a-011bdeb8e5b8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 4,
      "beatId": "1159cb70-ce54-4b95-8784-abd8efb4d24a",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation provides relief by showing the efficacy, safety, and tolerability of efgartigimod.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}